Related Experiment Videos
[Pathologic grading and clinical features of chronic hepatitis B]
Hongbo Ma1, Zhenwei Lang, Ronghua Jin
1Beijing Youan Hospital, Beijing 100054, China.
Summary
Clinical diagnosis accuracy for chronic hepatitis B (CHB) can be improved by considering symptoms and biochemical markers. Diagnosis alignment with pathology varied by disease severity, being lowest in moderate CHB.
Area of Science:
- Hepatology
- Clinical Diagnostics
- Biochemistry
Context:
- Chronic hepatitis B (CHB) diagnosis relies on clinical assessment and biochemical tests.
- Histopathological data is crucial for staging and grading CHB.
- Accurate diagnosis is essential for effective patient management.
Purpose:
- To evaluate the correlation between clinical features, biochemical markers, and histopathological data in CHB patients.
- To determine the accuracy of clinical diagnosis across different stages of CHB.
- To identify key indicators for improving CHB diagnostic accuracy.
Summary:
- A study of 202 CHB patients analyzed the relationship between clinical symptoms, biochemical tests (including total bilirubin, albumin, prothrombin activity, ALT, A/G ratio, and r-globulin), and histopathology.
- Results showed significant associations between clinical/biochemical findings and histological grade/stage.
- Diagnostic accuracy was highest in mild CHB (63.8%-79.0%), moderate in marked CHB (40.0%-62.5%), and lowest in moderate CHB (10.0%-28.2%).
Impact:
- Highlights the importance of clinical symptoms and signs in CHB diagnosis.
- Suggests potential for refining diagnostic criteria, particularly for moderate CHB.
- Aims to enhance the precision of clinical diagnosis for chronic hepatitis B.